Botify Launches Botify Activation to Accelerate Speed to Market and Content Discoverability for the World’s Most Ambitious Brands
Botify, a leading performance marketing platform for organic search, today announced the launch of Botify Activation to empower organizations to regain control of how search engines and consumers find products and services organically online.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230131005318/en/
A key suite within the Botify Platform, which already includes Botify Analytics and Botify Intelligence, Botify Activation connects insights about a website’s performance with making brands more discoverable online. By enabling scalable, automated site improvements and content discoverability, Botify Activation provides brands with the ability to expedite how search engines discover and interpret website pages—improving speed to market while also boosting efficiency across teams.
Specifically, Botify Activation is comprised of the following solutions:
- SpeedWorkers: Serves fully-rendered pages to search engines, ensuring more content can be crawled, indexed, and ultimately found to drive traffic and revenue
- PageWorkers: Automation capabilities that allow brands to make organic search changes to their website quickly and at scale
- FastIndex: Easily generate optimized sitemaps to ensure that search engines prioritize the most critical content on your website
"Botify Activation has given us confidence that our strategic pages – ones that drive sales critical to our business – are being found by search engines and by potential buyers. We’ve seen substantial growth in revenue tied to these product pages, which is crucial during the holiday season and throughout the rest of the year,” said Dave Han, VP of Product, Neiman Marcus Group.
Remaining in control of how consumers find content through organic search results, by ensuring search engines can see a brand’s most valuable content, is vital in today’s digital age. In fact, a recent survey conducted by Botify shared that one third of both U.S. and U.K. searchers said they would change their search terms if they were not satisfied with the initial results, as opposed to clicking through multiple results pages.
Botify Activation ensures that consumers find brands’ most relevant and strategic website pages during the initial search, creating touchpoints to maximize online revenue and reduce missed opportunities to connect with potential customers.
“We can rapidly respond to seasonal opportunities on our website quickly with Botify Activation as it enables us to make organic search optimizations at scale, without the need for dev resources. We were able to insert the most relevant Black Friday dynamic keywords across all our product pages in minutes using Botify Activation. Without it, those optimizations would have taken months to be implemented,” said Wayne Burden, Global Head of SEO, Ecco.
Further, in the same survey, more than half of U.S. and U.K. respondents reported that they sometimes follow or convert to a new brand when finding one through search. This demonstrates that meeting consumers at the right moment on their search journey is essential to establishing and building trust—impacting bottom line and future revenue.
“With the current economic uncertainty, companies are forced to do more with less to generate higher profitability. Botify Activation addresses this challenge by empowering search professionals to automatically make website improvements to ensure the utmost visibility,” said Adrien Menard, CEO of Botify. “With optimizations now made within minutes instead of months, for every $1 invested in Botify Activation, they can generate 3x more return than with traditional advertising campaigns.”
Read more about Botify Activation.
About Botify
Botify, a leading performance marketing platform for organic search, strengthens the digital brand experience by creating greater content findability. Using proprietary first-party data, Botify protects and scales organic web traffic by surfacing deeper insights and understanding behind hidden organic search ROI—offering intelligent opportunities to increase relevant search results, profitability and build better brand authority in parallel and at scale.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230131005318/en/
Contact information
Natasha Koleas
PAN Communications
949-397-7582
botify@pancomm.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma18.12.2025 12:00:00 CET | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation for BGB-B2033, its GPC3x4-1BB bispecific antibody for the treatment of adult patients with hepatocellular carcinoma (HCC) with disease progression on or after prior systemic treatment. “The FDA awards Fast Track Designation to therapies that show potential to address an unmet medical need in serious or life-threatening conditions. The FDA’s decision reflects the encouraging profile of BGB-B2033 in advanced hepatocellular carcinoma, where patients continue to face limited treatment options,” said Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer at BeOne. BeOne is currently conducting a global, multi-center Phase 1 clinical trial (NCT06427941) to explore the safety and anti-tumor activity of BGB-B2033, both alone and in combination with PD-1 inhibitor TEVIMBRA® (tisle
NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 10:53:00 CET | Press Release
NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press Release
Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeking future-ready solutions. At the core of this strategy is Regnology Risk Hub (RRiskHub), an integrated solution designed to deliver a single
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press Release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press Release
Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
